#1Year-end Report 2023 es ees es essity 100#2This presentation may contain forward-looking statements. Such statements are based on our current expectations and are subject to certain risks and uncertainties that could negatively affect our business. Please read our most recent annual and sustainability report for a better understanding of these risks and uncertainties. The amounts stated in this presentation pertain to Continuing Operations unless otherwise indicated. essity Year-end Report 2023 Rouettes HON S 116 WAT TORK HEROES JOBST Cutimed Sorbion Carbon 6 ero Up&Go - Regis 35424 Plenty EVERYDAY Sr ME Just Arde Libero touch 2 TORK Tork Xprese TENA Stoties IDENTIFI#3PABE ANG DAN For everybody and every body Every day our brands care for the hygiene and health of a billion people across 150 countries. TH es ees es TOM ORGANIC Actimove Nosotras Libero essity ΤΕΝΑ TORK Leukoplast Lotus modibodi JOBST knix Jempo Saba Libresse Zewa January 25, 2024 3#4Essity - A Global, Leading Hygiene and Health Company 147.1 18.9 essity Net sales 2023 SEKbn Year-end Report 2023 Adjusted EBITA 2023 SEKbn 36,000 employees VALLE Every day our brands care for the hygiene and health of a billion people across 150 countries#5Key Achievements 2023 Highest profit ever and strong platform for growth Substantially improved structural margins for all business areas Good progress on key priorities - innovation, efficiency and sustainability Pre-conditional public offer announced for the shares in Vinda – enabling more attractive portfolio essity Year-end Report 2023 Libresse Saba Bodyform#6Pre-conditional Public Offer Announced for 100% of Shares in Vinda Attractive offer yielding an annual return on the investment of approx. 14% at an EV/EBITDA multiple of 18.1x ▪ Isola Castle Ltd has announced that it will make a pre-conditional public offer to acquire 100% of Vinda for a price per share of HKD 23.5 ▪ Essity has signed an irrevocable undertaking to accept the offer in respect its 51.59% shareholding in Vinda Cash proceeds to Essity of approx. HKD 15bn (SEK 19bn) An exclusive license to continue to market and sell certain Essity branded products will be offered to Vinda after closing of the transaction to replace the existing license agreement ■ The transaction is expected to be completed mid-2024 Essity classifies the financial reporting of Vinda as discontinued operations as of Q4 2023 ■ ■ ■ essity Year-end Report 2023 Vinda #it January 25, 2024 6#7Long-term Portfolio Direction Net Sales Split 2022 23% 20% essity 16% 41% Health & Medical Net Sales Split 2023 27% 21% Professional Hygiene 19% 33% Long-term Direction Personal Care 25% 25% Consumer Goods Consumer Tissue 25% 25%#8Value Creating Acquisitions es ees e9 essity #0 familia asaleo care abigo COACH. ZONAS | ELASTIKON ● Legacy AquaCast LINER Hydrofera modibodi knix#92023 - Strong Sales Growth, Record High Adjusted EBITA 131,320 ee9 es Net Sales 2022 (SEKm) -3.7% essity Volume +9.5% Year-end Report 2023 Price/Mix 1) Including organic sales growth and acquisitions 2) Excluding items affecting comparability 3) Excluding items affecting comparability and amortization of acquisition-related intangible assets +0.9% Acquisitions Sales Growth ¹) +6.7% Reported Growth: +12.1% incl Divestments -1.3% Currency +6.7% 147,147 Net Sales 2023 (SEKm) Adjusted EBITA ²) SEK 18,898m +57% Adjusted ROCE²) 16.4% +550bps Adjusted EBITA Margin ²) 12.8% +360bps Adjusted Earnings per Share ³) SEK 17.56 +51% January 25, 2024 9#10Strong Development of Sales and Profits SEKbn Sales Growth ²) e9 101.5 2021 +4.0% 1) Excluding items affecting comparability 2) Including organic sales growth and acquisitions Net Sales essity Year-end Report 2023 +45% 131.3 2022 + 19.7% 147.1 2023 +6.7% SEKbn Adjusted EBITA Margin¹) Adjusted EBITA 1) 11.5 2021 + 11.3% +65% 12.0 2022 +9.2% 18.9 2023 +12.8% January 25, 2024 10#11Strong Development of Sales and Profits Adjusted EBITA 1) SEKbn 88.0 e9 ee9 es 2014 Sales Growth 2) 98.5 101.2 Net Sales 109.3 118.5 129.0 121.8 1) Excluding items affecting comparability 2) Including organic sales growth and acquisitions 2014-2020 Not restated. 2021-2023 Vinda classified as discontinued operations. essity Year-end Report 2023 101.5 131.3 147.1 2015 2016 2017 2018 2019 2020 2021 2022 2023 +6% +6% +7.5% +5.0% +4.5% -1.8% +4.0% +19.7% +6.7% SEKbn 9.5 2014 10.6 12.0 13.4 12.9 15.8 17.6 11.5 12.0 18.9 2015 2016 2017 2018 2019 2020 2021 2022 2023 Adjusted EBITA Margin ¹) 10.8% 10.8% 11.8% 12.3% 10.9% 12.3% 14.5% 11.3% 9.2% 12.8% January 25, 2024 11#12Dividend Proposed Dividend ¹) e9 ee9 es SEK 7.75 +7% 1) Board of Directors Proposal essity Year-end Report 2023 5.75 2018 6.25 2019 6.75 7.00 Dividend Growth +35% 2020 2021 7.25 2022 7.751) 2023 January 25, 2024 12#13Financial Summary Q4 2023 vs Q4 2022 Net Sales e9 ee9 es SEK 36,625m +0% Adjusted EBITA Margin²) 13.3% +210bps Sales Growth ¹) -0.7% Organic: -0.7% Adjusted ROCE²) 17.1% +320bps 1) Including organic sales growth and acquisitions 2) Excluding items affecting comparability 3) Excluding items affecting comparability and amortization of acquisition-related intangible assets essity Year-end Report 2023 Adjusted EBITA ²) SEK 4,853m +18% Adjusted Earnings per Share ³) SEK 4.54 +21% knix#14Positive Mix and Higher Underlying Volumes 36,629 ee9 es Net Sales Q4 2022 (SEKm) 1) Including organic sales growth and acquisitions essity Year-end Report 2023 -1.4% Volume +0.7% Price/Mix Sales Growth ¹) -0.7% Reported Growth: 0% incl Divestments -2.5% Currency +3.2% 36,625 Net Sales Q4 2023 (SEKm) Volume growth of +1.2% excluding restructuring in Professional Hygiene and deliberate exits of contracts with insufficient profitability in Incontinence Products Health Care and Baby Care Better mix +0.9% Prices down -0.2% January 25, 2024 14#15Higher Adjusted EBITA Margin 11.2% Adj EBITA Margin¹) Q4 2022 1) Excluding items affecting comparability ee9 +410bps +210bps + Better mix + Cost savings + Lower costs for raw materials and distribution Impact Gross Profit Margin -40bps - Higher energy costs - Lower prices and volumes - Salary inflation essity Year-end Report 2023 A&P -160bps SG&A (excl A&P) 13.3% Adj EBITA Margin ¹) Q4 2023 Adjusted EBITA margin growth driven by better mix and cost savings of SEK 377m as well as lower costs for raw material and distribution. A&P higher to support product launches SG&A higher mainly related to salary inflation January 25, 2024 15#16Health & Medical es essity Ch 1 Fixomull stretch p MANAGE EXUDATE I RÉGULATION DE L'EXSUDAT neret 3 P hydration RESPONSE technology Wele Cutimed Sorbion® Carbon+ Odor-binding superabsorbent dressing Pansement superabsorbant neutralisateur d'odeurs Geruchsbindender superabsorbierender Wundverband 20 10x STERILE EO - A 39 FOOL E HELS 15x15cm 16x600-0000 ΤΕΝΑ Leukoplast JOBST Actimove® AquaCast LINER Cutimed Hydrofera Delta-Cast#17Health & Medical Good Sales Growth and Strong Margin Development 6,589 Net Sales Q4 2022 (SEKm) e9 ees es -2.8% Volume Price/Mix +7.1% Sales Growth ¹) +4.3% 1) Including organic sales growth and acquisitions 2) Excluding items affecting comparability Reported Growth: +6.3% incl Divestment -1.2% Currency +3.2% essity Year-end Report 2023 7,001 Net Sales Q4 2023 (SEKm) SEK 1,125m +57% 16.1% +520bps Adjusted EBITA²) Adjusted EBITA Margin2) Incontinence Products Health Care +3.4% Higher prices and better mix Lower volumes related to exits of contracts with inadequate profitability Medical Solutions +5.4% Good growth in all three product segments; Wound Care, Compression Therapy and Orthopedics Significantly higher adjusted EBITA and adjusted EBITA margin January 25, 2024 17#18es ees e9 Consumer Goods essity Saba ba Saba diario V-NATU BON CE VIDUTTOR 47 Sabe tegi 10ULT DELGADA teen 116 SLOADA RNA Fa 112 RATRAL BERIT 12 V-NATURE Ⓒ diario fresh. Saba Saba ens ULTRADELG ΤΕΝΑ Libero Lotus Baby Libresse Saba Bodyform ΤΟΜ ORGANIC knix modibodi Lotus Zewa Jempo#19Consumer Goods Strong Growth in Inco and Feminine, Baby Turnaround 20,454 Net Sales Q4 2022 (SEKm) -0.8% ee9 es Volume 1) Including organic sales growth and acquisitions 2) Excluding items affecting comparability essity -2.0% Sales Growth ¹) -2.8% Price/Mix Reported Growth: -2.9% incl Divestments -3.5% Currency +3.4% Year-end Report 2023 19,870 Net Sales Q4 2023 (SEKm) SEK 2,585m +13% 13.0% +180bps Adjusted EBITA²) Adjusted EBITA Margin²) Incontinence Products Retail +9.8% & Feminine Care +16.5% Higher volumes, higher prices and better mix Baby Care +2.0% Higher prices and better mix Consumer Tissue -10.3% Focus on profitable growth and margins Higher adjusted EBITA and adjusted EBITA margin January 25, 2024 19#20Professional Hygiene e9 ees eg essity TORK Think ahead.#21Professional Hygiene Strong Underlying Volume Growth in High Margin Segments 9,617 Net Sales Q4 2022 (SEKm) ee9 es -1.7% Volumes Price/Mix +1.8% Sales Growth ¹) +0.1% 1) Including organic sales growth and acquisitions 2) Excluding items affecting comparability essity Reported Growth: +1.4% incl Divestment -1.3% Currency +2.6% Year-end Report 2023 9,752 Net Sales Q4 2023 (SEKm) SEK 1,531m +9% 15.7% +110bps Adjusted EBITA²) Adjusted EBITA Margin2) Lower volumes due to restructuring in USA and Europe partly compensated by strong underlying growth Higher adjusted EBITA and adjusted EBITA margin January 25, 2024 21#22Progress on Key Priorities 2023 Y Innovation & Brands Price Management +8.9% in Price Strong price effect while still successfully protecting our #1 and #2 positions essity Year-end Report 2023 +0.6% in Mix Growth in high margin product segments and important product launches Portfolio of growing and trusted brands used by one billion people world-wide TORK Libero knix Jempo JOBST Actimove Regio ΤΕΝΑ Libresse SEK 433m generated from cost savings Examples: Cost Efficiency • Operational efficiency Digitalization • Raw material rationalization Fiber mix ● ● Sourcing negotiations E-save 7– Growth in Fastest Growing Categories and Channels Inco Retail +14% Feminine Care +13% Compression +10% Knix +18% Hydrofera +23% Legacy +19% E-commerce +10% to 9% of net sales 2023 0 Leading in Sustainability Science Based Targets Scope 1 and 2 vs 2016 Target 2030: Outcome 2023: -35% -26% • Ranked as one of the world's most sustainable companies by Corporate Knights. The Global 100 list represents the top 1% of companies in the world in terms of sustainability performance. Recognized as a diversity leader by Financial Times January 25, 2024 22#23Innovations Q4 2023 MEDICAL SOLUTIONS JOBST/ JOBST® Elvarex® essity Year-end Report 2023 14 Saba invisible DELGADA Protection & Comod dad Saba FLUJO ABUNDANTE FEMININE CARE Saba Invisible Sanitary Towels WASTE LESS W PLASTIC 100% R Libresse intimawear YOUR PERIOD'S IN GOOD PANTS RELIABLE PROTECTION LEWING YOU FREE 10 DO WHATEVER YOU 40 YEARS OF V-ZONE EXPERIENCE PERIOD PANTS Intimawear by Libresse / Sleepwear ½ Blatt Zewa CONSUMER TISSUE G Kompostierbare Tücher Zewa WISCH Sparblatt Weniger Verschwendung 1Blatt RINGFEST So stark-bis zu 3x verwendbar" Zewa® Wisch & Weg Plenty 40% MORE ABSORBENT Plenty the Original one CERTIFIED COMPOSTABLE SHEETS For your SRINGABLA POWER-X PlentyⓇ (2) 200 January 25, 2024 23#24Innovations Q4 2023 TORK Think ahead. TORK 2 in 1 Scouring and Cleaning Cloth 45 01 50 Absorbent + TORK OL Tork 2 in 1 Scouring and Cleaning Foodservice Towel (NA) Tork 2 in 1 Scouring and Cleaning Cloth (EU) essity Year-end Report 2023 TORK TORK Extra Mild Hand Washing Foam Soap 40 00 39 2L Tork Counter Mount Soap System PROFESSIONAL HYGIENE TORK Air Freshener Breeze 25 70 10 UP PP-DP Content: 32ml C FI TORK Tork Constant Air Freshener System TORK Advanced H2 Tork Xpress® Multifold with 68% carbon footprint reduction TORK Think ahead. We now also offer Tork carbon-neutral dispensers Tork® carbon neutral dispensers January 25, 2024 24#25Superiority Share of Net Sales with Superiority 40% 2017 essity Year-end Report 2023 56% 2020 62% 2023 Libero#26Leading Where We Choose to Play #1 or #2 ~90% e9 ees eg of branded sales essity #1 -60% Source: The information has been compiled by Essity for presentation purposes based on data taken from external market sources including but not limited to retail audit companies, Price Hanna Consultants, SmartTRAK, Fastmarkets RISI and national macroeconomic data. Year-end Report 2023 of branded sales Higher Market Shares >60% Last 3 years January 25, 2024 26#27Summary 2023 ▪ Record profits and strong platform for growth I ■ Pre-conditional offer for Vinda improving capital efficiency and reducing earnings volatility Health & Medical decisive pricing leading to significantly improved margins ■ Consumer Goods: - Continued positive momentum in Feminine Care and Incontinence Product Retail in all key markets Turnaround of Baby Care Successful price management in Consumer Tissue leading to high and stable margins ▪ Professional Hygiene - major restructuring adding -200bps higher structural margin essity Year-end Report 2023 GREAT FOR YOU AND THE PLANET KEEP CONTROL TENA MEN WASHABLE MACARRERALE LA PROTECTIVE BOXER FOR DRIPS & DRIBBLES O X1 ZONE#28Priorities 2024 Strong platform for growth ▪ Volume growth in high yielding segments Innovation, brands and market shares gains ■ ■ Price management ■ Operational efficiency and digitalization ■ Continued progress on ESG essity Year-end Report 2023 **** JOBST Ⓡ RACE WW#29Thermodyne ARRA Les ees eg Q&A Adina essity 000#30e9 ees es essity